Portfolio Update
24 September 2021 - 4:45PM
Portfolio Update
The Board of OT3 VCT notes that Arecor Therapeutics plc
(Arecor), which at 31 May 2021 was 23 % of the OT3 NAV of
44.4p/share was based on an Arecor share price of £2.26 which has
now risen to £4.30 bid price as at market close on 23 September. In
isolation, each 100p change in Arecor's share price has a 4.4p
impact on the NAV of OT3 VCT.
The Board are in the process of preparing the accounts for the
half year ending 31 August 2021, which will including further
details of the valuation of the rest of the portfolio. These are
expected to be issued in October.
For further information please contact: Lucius Cary 01865
784466
This announcement contains inside information as stipulated
under the UK version of the Market Abuse Regulation No 596/2014
which is part of English Law by virtue of the European (Withdrawal)
Act 2018, as amended. Upon the publication of this announcement via
a Regulatory Information Service, this information is now
considered to be in the public domain.
Oxford Technology 3 Vent... (LSE:OTT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Oxford Technology 3 Vent... (LSE:OTT)
Historical Stock Chart
From Apr 2023 to Apr 2024
Real-Time news about Oxford Technology 3 Venture Capital Trust Plc (London Stock Exchange): 0 recent articles
More News Articles